BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20605352)

  • 21. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
    Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
    Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
    Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events.
    Songthong AP; Kannarunimit D; Chakkabat C; Lertbutsayanukul C
    Radiat Oncol; 2015 Aug; 10():166. PubMed ID: 26253488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.
    Kam MK; Chau RM; Suen J; Choi PH; Teo PM
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):145-57. PubMed ID: 12694833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of changing gross tumor volume delineation of intensity-modulated radiotherapy on the dose distribution and clinical treatment outcome after induction chemotherapy for the primary locoregionally advanced nasopharyngeal carcinoma].
    Yu Z; Luo W; Zhou QC; Zhang QH; Kang DH; Liu MZ
    Ai Zheng; 2009 Nov; 28(11):1132-7. PubMed ID: 19895731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study.
    Wu F; Wang R; Lu H; Wei B; Feng G; Li G; Liu M; Yan H; Zhu J; Zhang Y; Hu K
    Radiother Oncol; 2014 Jul; 112(1):106-11. PubMed ID: 24933452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma.
    Iuchi T; Hatano K; Kodama T; Sakaida T; Yokoi S; Kawasaki K; Hasegawa Y; Hara R
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):793-800. PubMed ID: 24495592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dosimetric inadequacy on local control and toxicities in the patients with T4 nasopharyngeal carcinoma extending into the intracranial space and treated with intensity-modulated radiotherapy plus chemotherapy.
    Xue F; Hu CS; He XY
    Chin J Cancer; 2017 Sep; 36(1):76. PubMed ID: 28931426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma.
    Kwong DL; Sham JS; Leung LH; Cheng AC; Ng WM; Kwong PW; Lui WM; Yau CC; Wu PM; Wei W; Au G
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):374-81. PubMed ID: 16213105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma.
    Qiu S; Lin S; Tham IW; Pan J; Lu J; Lu JJ
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):676-83. PubMed ID: 22024207
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
    Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.
    Bi XW; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Ren H; Dai JR
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1086-93. PubMed ID: 24120822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Wong FC; Ng AW; Lee VH; Lui CM; Yuen KK; Sze WK; Leung TW; Tung SY
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):138-45. PubMed ID: 19646824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.
    Xiang L; Rong JF; Xin-Chen ; Li XY; Zheng Y; Ren PR; Lin S; Wen QL; He LJ; Zhang JW; Shang CL; Yang HR; Fan J; Pang HW; Zhang J; Tan BX; Zhang L; Du XB; Wen SM; Jiang L; Qin G; Wu JB
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):914-924. PubMed ID: 37356553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma.
    Lee SW; Back GM; Yi BY; Choi EK; Ahn SD; Shin SS; Kim JH; Kim SY; Lee BJ; Nam SY; Choi SH; Kim SB; Park JH; Lee KK; Park SH; Kim JH
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):152-60. PubMed ID: 16472934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy.
    Alterio D; D'Ippolito E; Vischioni B; Fossati P; Gandini S; Bonora M; Ronchi S; Vitolo V; Mastella E; Magro G; Franco P; Ricardi U; Krengli M; Ivaldi G; Ferrari A; Fanetti G; Comi S; Tagliabue M; Verri E; Ricotti R; Ciardo D; Jereczek-Fossa BA; Valvo F; Orecchia R
    Acta Oncol; 2020 May; 59(5):541-548. PubMed ID: 32090645
    [No Abstract]   [Full Text] [Related]  

  • 38. Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer.
    Tham IW; Lin S; Pan J; Han L; Lu JJ; Wee J
    Am J Clin Oncol; 2010 Jun; 33(3):294-9. PubMed ID: 20395788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local regression and control of T1-2 nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Xue F; Ou D; Hu C; He X
    Cancer Med; 2018 Dec; 7(12):6010-6019. PubMed ID: 30406969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
    Kim K; Wu HG; Kim HJ; Sung MW; Kim KH; Lee SH; Heo DS; Kim HJ; Park CI
    Head Neck; 2009 Sep; 31(9):1121-8. PubMed ID: 19340863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.